Predicting menstrual migraine with a home-use fertility monitor

Neurology. 2005 Feb 8;64(3):561-3. doi: 10.1212/01.WNL.0000150547.85002.61.

Abstract

A home-use fertility monitor was used to time perimenstrual prophylaxis in 27 women with menstrual or menstrually related migraine. Cycle length variability was mostly caused by follicular phase variability; the postovulatory luteal phase was relatively constant. The monitor accurately identified ovulation in >90% of cycles, enabling prediction of menstruation and precise timing of perimenstrual prophylaxis. Ninety-seven percent of women found the monitor useful in predicting menstrual migraine attacks.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Algorithms
  • Computers, Handheld*
  • Estradiol / administration & dosage
  • Estradiol / therapeutic use
  • Estrone / analogs & derivatives*
  • Estrone / urine
  • Female
  • Follicle Stimulating Hormone / urine
  • Follicular Phase
  • Forecasting
  • Gels
  • Humans
  • Luteal Phase
  • Luteinizing Hormone / urine*
  • Middle Aged
  • Migraine Disorders / etiology*
  • Ovulation Detection / instrumentation
  • Ovulation Detection / methods*
  • Pregnanediol / analogs & derivatives
  • Pregnanediol / urine
  • Premenstrual Syndrome / complications*
  • Premenstrual Syndrome / drug therapy
  • Reagent Strips*
  • Self Care / instrumentation
  • Self Care / methods*
  • Time Factors

Substances

  • Gels
  • Reagent Strips
  • pregnanediol-3 alpha-glucuronide
  • estrone-3-glucuronide
  • Estrone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Pregnanediol